In this post, we will be taking a closer look at some of the most popular cardiology-related articles that have been published during the months of April and May 2024.
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures
- JAMA Cardiology
- April 2024
- The association between antibiotic prophylaxis and infective endocarditis after invasive dental procedures is still unclear. Indications for antibiotic prophylaxis were restricted by guidelines beginning in 2007. To systematically review and analyze existing evidence on the association between antibiotic prophylaxis and infective endocarditis following invasive dental procedures.
- Abstract Link
- Full Text Link
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association
- Circulation
- April 2024
- The lack of randomized clinical trials in cardiac sarcoidosis has led to treatment decisions based on cohort studies and consensus opinions, with substantial variation observed across centers. This scientific statement is intended to guide clinical practice and to facilitate management conformity by providing a framework for the diagnosis and management of cardiac sarcoidosis.
- Abstract Link
- Full Text Link
Stress and Cardiovascular Disease: an Update
- Nature Reviews Cardiology
- May 2024
- Psychological stress has long been associated with negative health consequences, particularly cardiovascular disease, but the mechanisms and potential causal links have remained speculative. Physiological responses to stress are emerging as key pathways for the risk of cardiovascular disease, especially haemodynamic, vascular and immune perturbations triggered by stress. More data are needed from prospective studies and from assessments in real-life situations.
- Full Text Link
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity
- Journal of the American College of Cardiology (JACC)
- April 2024
- The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
- Abstract Link
- Full Text Link
Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure
- Hypertension
- April 2024
- Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).
- Abstract Link
- Full Text Link
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity
- Journal of the American College of Cardiology (JACC)
- April 2024
- The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
- Abstract Link
- Full Text Link
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control
- Hypertension (AHA Journals)
- April 2024
- In this review, we address this deficiency by examining and advocating for the incorporation of dietary fiber as a key lifestyle modification to manage elevated BP. We explain what dietary fiber is, review the existing literature that supports its use to lower BP and prevent cardiovascular disease, describe the mechanisms involved, propose evidence-based target levels of fiber intake, provide examples of how patients can achieve the recommended targets, and discuss outstanding questions in the field.
- Abstract Link
- Full Text Link
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- The New England Journal of Medicine (NEJM)
- April 2024
- Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker-based diagnosis of myocardial infarction and treatment with percutaneous coronary intervention, antithrombotic agents, high-intensity statins, and renin-angiotensin-aldosterone system antagonists.
- Abstract Link
- Full Text Link
Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure
- Hypertension
- April 2024
- Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).
- Abstract Link
- Full Text Link
Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
- Annals of Internal Medicine
- April 2024
- Salt substitution is a simple yet increasingly promising strategy to improve cardiovascular outcomes.
- Abstract Link
- Full Text Link
Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity
- Journal of the American College of Cardiology (JACC)
- April 2024
- The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
- Abstract Link
- Full Text Link
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control
- Hypertension (AHA Journals)
- April 2024
- In this review, we address this deficiency by examining and advocating for the incorporation of dietary fiber as a key lifestyle modification to manage elevated BP. We explain what dietary fiber is, review the existing literature that supports its use to lower BP and prevent cardiovascular disease, describe the mechanisms involved, propose evidence-based target levels of fiber intake, provide examples of how patients can achieve the recommended targets, and discuss outstanding questions in the field.
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine — Oregon, June 2021–December 2022
- Morbidity and Mortality Weekly Report (MMWR)
- April 2024
- To determine risk for sudden cardiac death among adolescents and young adults after COVID-19 vaccination, investigators examined June 2021–December 2022 Oregon death certificate data for decedents aged 16–30 years. Of 40 deaths that occurred among persons who had received an mRNA COVID-19 vaccine dose, three occurred ≤100 days after vaccination. Among these, two occurred in persons with underlying.
- Full Text Link
There you have it – a look at some of the most popular cardiology publications released in April and May 2024. Sign up for alerts and stay informed on the latest published guidelines and articles.
Copyright © 2024 Guideline Central, All rights reserved.